The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

By E.J.A. Kroot, B. D. de Jong, Miek A. van Leeuwen, Hilde Swinkels, F. V. D. van den Hoogen, M. van 't Hof, L. van de Putte, M. V. van Rijswijk, W. V. van Venrooij, P. V. van Riel. Arthritis & Rheumatism, 2000

700 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/72936eefef05d42c420887efa550032733e13d77

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. T. Huizinga
2. L. Criswell
3. A. H. M. van der Helm-van Mil
4. R. Toes
5. C. Amos
6. P. Gregersen
7. F. Breedveld
8. F. V. van Gaalen

Citations in the corpus

• Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. (2005, background): “Previous research has demonstrated, within the RA population, an association between HLA alleles and anti-CCP antibodies, but no comparison has been made between the HLA profile in the healthy population and that in RA patients who do or do not produce anti-CCP antibodies (8, 9 ,11).”